While ongoing manufacturing is not impacted, the USFDA's action the may affect the process of review of pending submissions from the facility for approval of new products, till the time the OAI status is not resolved.
Cellular operators body COAI today termed TRAI's consultation paper on call connect charges as "unfair on incumbent operators", and questioned the regulator's urgency in initiating the process of interconnect review, which the association claimed "favours new entrants".